Madrigal pharmaceuticals presents five health economics outcomes research abstracts at the nash-tag annual conference

Conshohocken, pa., jan. 04, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today announced five health economics abstracts being presented at the nash-tag conference, taking place from january 4-6, 2024 in park city, utah.
MDGL Ratings Summary
MDGL Quant Ranking